Potential therapeutic effect of epigenetic therapy on treatment-induced neuroendocrine prostate cancer

Potential therapeutic effect of epigenetic therapy on treatment-induced neuroendocrine prostate cancer

Although adenocarcinomas of the prostate are relatively indolent, some patients with advanced adenocarcinomas show recurrence of treatment-induced neuroendocrine prostate cancer, which is highly aggressive and lethal. Detailed biological features of treatment-induced neuroendocrine prostate cancer h...

Full description

Bibliographic Details
Main Authors:	Xiang Xu, Yu-Hua Huang, Yan-Jing Li, Alexa Cohen, Zhen Li, Jill Squires, Wei Zhang, Xu-Feng Chen, Min Zhang, Jiao-Ti Huang
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2017-01-01
Series:	Asian Journal of Andrology
Subjects:	cancer stem cell; epigenetic therapy; hormonal therapy; neuroendocrine prostate cancer; suberoylanilide hydroxamic acid
Online Access:	http://www.ajandrology.com/article.asp?issn=1008-682X;year=2017;volume=19;issue=6;spage=686;epage=693;aulast=

Similar Items

Adjuvant Epigenetic Therapy of Decitabine and Suberoylanilide Hydroxamic Acid Exerts Anti-Neoplastic Effects in Acute Myeloid Leukemia Cells
by: Sonia Abou Najem, et al.
Published: (2019-11-01)

Androgen-deprivation therapy-induced aggressive prostate cancer with neuroendocrine differentiation
by: Julia Lipianskaya, et al.
Published: (2014-08-01)

Current advances of targeting epigenetic modifications in neuroendocrine prostate cancer
by: Wen-Chi Cheng, et al.
Published: (2021-01-01)

The Calcium-Sensing Receptor is A Marker and Potential Driver of Neuroendocrine Differentiation in Prostate Cancer
by: Fanny Bery, et al.
Published: (2020-04-01)

Molecular and Functional Links between Neurodevelopmental Processes and Treatment-Induced Neuroendocrine Plasticity in Prostate Cancer Progression
by: Roosa Kaarijärvi, et al.
Published: (2021-02-01)

Application of Electric Cell-Substrate Impedance Sensing to Investigate the Cytotoxic Effects of Andrographolide on U-87 MG Glioblastoma Cell Migration and Apoptosis
by: Sheng-Po Chiu, et al.
Published: (2019-05-01)

Changes in the Expression of TBP-2 in Response to Histone Deacetylase Inhibitor Treatment in Human Endometrial Cells
by: Hye In Kim, et al.
Published: (2021-01-01)

Neuroendocrine differentiation in prostate cancer – a review
by: R. Popescu, et al.
Published: (2015-12-01)

Targeting developmental regulators of zebrafish exocrine pancreas as a therapeutic approach in human pancreatic cancer
by: Nelson S. Yee, et al.
Published: (2012-02-01)

Inhibition of histone-deacetylase activity rescues inflammatory cystic fibrosis lung disease by modulating innate and adaptive immune responses
by: Manish Bodas, et al.
Published: (2018-01-01)

Neuroendocrine aspects of prostate oncogenesis
by: P.V. Glybochko, et al.
Published: (2010-03-01)

MicroRNAs as Epigenetic Determinants of Treatment Response and Potential Therapeutic Targets in Prostate Cancer
by: Valentina Doldi, et al.
Published: (2021-05-01)

Neuroendocrine Differentiation of Prostate Cancer—An Intriguing Example of Tumor Evolution at Play
by: Girijesh Kumar Patel, et al.
Published: (2019-09-01)

Targeting neuroendocrine prostate cancer: molecular and clinical perspectives
by: Panagiotis J Vlachostergios, et al.
Published: (2015-02-01)

Interplay between Epigenetics, Expression of Estrogen Receptor- α, HER2/ERBB2 and Sensitivity of Triple Negative Breast Cancer Cells to Hormonal Therapy
by: Wafaa S Ramadan, et al.
Published: (2018-12-01)

Gross Findings of Widespread Visceral Metastasis of Prostatic Adenocarcinoma With Neuroendocrine Features: A Case Report
by: David J. Habibian, et al.
Published: (2016-09-01)

ING5‐mediated antineuroblastoma effects of suberoylanilide hydroxamic acid
by: Ji‐cheng Wu, et al.
Published: (2018-09-01)

Mixed adenocarcinoma and neuroendocrine prostate cancer: a case report
by: Rittu Hingorani, et al.
Published: (2014-11-01)

Neuroendocrine and Aggressive-Variant Prostate Cancer
by: Nicholas Spetsieris, et al.
Published: (2020-12-01)

Pancreatic metastasis from locally recurrent neuroendocrine differentiated prostate cancer after radical prostatectomy
by: Takashi Ando, et al.
Published: (2020-07-01)

Design, Synthesis and Biological Evaluation of Hydroxamic Acid Derivatives as Potential High Density Lipoprotein (HDL) Receptor CLA-1 Up-Regulating Agents
by: Yu Du, et al.
Published: (2011-11-01)

In vivo efficacy of the histone deacetylase inhibitor suberoylanilide hydroxamic acid in combination with radiotherapy in a malignant rhabdoid tumor mouse model
by: Thiemann Markus, et al.
Published: (2012-03-01)

Clinical Epigenetics of Neuroendocrine Tumors: The Road Ahead
by: Annamaria Colao, et al.
Published: (2020-12-01)

Molecular Links Between Angiogenesis and Neuroendocrine Phenotypes in Prostate Cancer Progression
by: Zheng Wang, et al.
Published: (2020-01-01)

Primary metastatic prostate cancer between prognosis or adequate/proper medical therapy
by: Mahmoud Mustafa, et al.
Published: (2021-01-01)

NEUROENDOCRINE CARCINOMA OF THE PROSTATE: A CASE REPORT
by: I. Ya. Skvortsov, et al.
Published: (2014-07-01)

NEUROENDOCRINE CARCINOMA OF THE PROSTATE: A CASE REPORT
by: I. Ya. Skvortsov, et al.
Published: (2014-07-01)

Alternative splicing of LSD1+8a in neuroendocrine prostate cancer is mediated by SRRM4
by: Daniel J. Coleman, et al.
Published: (2020-06-01)

Phase I trial of TAK‐385 in hormone treatment‐naïve Japanese patients with nonmetastatic prostate cancer
by: Hiroyoshi Suzuki, et al.
Published: (2019-10-01)

Antimicrobial Metabolites Produced by Penicillium mallochii CCH01 Isolated From the Gut of Ectropis oblique, Cultivated in the Presence of a Histone Deacetylase Inhibitor
by: Shuxiang Zhang, et al.
Published: (2019-10-01)

p53-Mediated Molecular Control of Autophagy in Tumor Cells
by: Maria Mrakovcic, et al.
Published: (2018-03-01)

Combination of suberoylanilide hydroxamic acid with heavy ion therapy shows promising effects in infantile sarcoma cell lines
by: Kulozik Andreas E, et al.
Published: (2011-09-01)

HDAC inhibitor SAHA normalizes the levels of VLCFAs in human skin fibroblasts from X-ALD patients and downregulates the expression of proinflammatory cytokines in Abcd1/2-silenced mouse astrocytes
by: Jaspreet Singh, et al.
Published: (2011-11-01)

Vorinostat (SAHA) and Breast Cancer: An Overview
by: Anna Wawruszak, et al.
Published: (2021-09-01)

Histone Deacetylase Inhibitor SAHA Improves High Salinity Tolerance Associated with Hyperacetylation-Enhancing Expression of Ion Homeostasis-Related Genes in Cotton
by: Shibin He, et al.
Published: (2020-09-01)

Gene Expression Signature Predictive of Neuroendocrine Transformation in Prostate Adenocarcinoma
by: Paola Ostano, et al.
Published: (2020-02-01)

Function of Tumor Suppressors in Resistance to Antiandrogen Therapy and Luminal Epithelial Plasticity of Aggressive Variant Neuroendocrine Prostate Cancers
by: Rama Soundararajan, et al.
Published: (2018-03-01)

Dermatomyositis associated with prostate adenocarcinoma with neuroendocrine differentiation
by: Hideyuki Minagawa, et al.
Published: (2021-01-01)

Development and prevalence of castration-resistant prostate cancer subtypes
by: Jordan E. Vellky, et al.
Published: (2020-11-01)

Editorial: Response and Resistance in Castration-Resistant Prostate Cancer
by: Renée de Leeuw, et al.
Published: (2020-10-01)